Résumé
L’intérêt du dépistage et les moyens à mettre en œuvre pour dépister une coronaropathie chez les diabétiques asymptomatiques de type 2 restent l’objet de controverses. Les cardiopathies ischémiques et l’insuffisance cardiaque sont la première cause de mortalité et de morbidité chez les diabétiques et la prévalence des diabétiques dans la population générale ne cesse d’augmenter, ce qui pose un problème de santé publique. Plusieurs questions restent d’actualité
-
le dépistage de l’ischémie silencieuse doit-ilêtre systématique dans cette population ou doit-ilêtre ciblé en fonction de facteurs de risque associés?;
-
ce dépistage est-il bénéfique pour le pronostic à long terme du patient?;
-
Quel examen, ou quelle stratégie diagnostique, est le plus efficace pour évaluer ces patients asymptomatiques? Nous nous intéresserons ici aux patients diabétiques de type 2 sans cardiopathie ischémique connue.
Preview
Unable to display preview. Download preview PDF.
Références
Fagot-Campagna A, Romon I, Fosse S, Roudier C (2010) Prévalence et incidence du diabète, et mortalité liée au diabète en France — Synthèse épidémiologique. Saint-Maurice (Fra): Institut de veille sanitaire, novembre 2010, 12 p. Disponible sur: http://www.invs.sante.fr
Stamler J, Wentworth D, Neaton J, for the MRFIT Research Group (1986) The Multiple Risk Factor Intervention Trial (MRFIT). Importance then and now. JAMA 256: 2823–8
American Diabetes Association (2012) Executive summary: standards of medical care in diabetes. Diabetes Care 35: S4–S10
Perk J, De Backer G, Gohlke H, et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012 The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33: 1635–701
Milan Study on Atherosclerosis and Diabetes (MiSAD) Group (1997) Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin-dependent diabetes mellitus. Am J Cardiol 79: 134–9
Janand-Delenne B, Savin B, Habib G, et al. (1999) Silent myocardial ischemia in patients with diabetes. Who to screen. Diabetes Care 22:1396–400
Kim MK, Baek KH, Song KH, et al. (2011) Exercise treadmill test in detecting asymptomatic coronary artery disease in type 2 diabetes mellitus. Diabetes Metab J 35: 34–40
Djaberi R, Beishuizen ED, Pereira AM, et al. (2008) Non-invasive imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus. Diabetologica 51:1581–93
Albers A, Krichavsky M, Balady G (2006) Stress testing in patients with diabetes mellitus. Diagnostic and prognostic value. Circulation 113: 583–92
Greenland P, Alpert JS, Belier GA, et al. (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary. Circulation 122:2748–64
Scognamiglio R, Negut C, Ramondo A, et al. (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol 47: 65–71
De Lorenzo A, Lima R, Siqueira-Fihlho A, Pantoja M (2002) Prevalence and pronostic value of perfusion defects detected by Technetium 99m Sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 90: 827–32
Wackers FJ, Young LH, Inzucchi SE et al. (2004) Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27:1954–61
Young LH, Wackers FJ, Chyun DA, et al. (2009) Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes. The DIAD Study: A Randomized Controlled Trial. JAMA 301: 1547–55
Perrone-Filardi P, Achenbach S, Möhlenkamp S, et al. (2011) Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur Heart J 32:1986–93
Schuijf JD, Mollet NR, Cademartiri F et al. (2006) Do risk factors influence the diagnostic accuracy of noninvasive coronary angiography with multislice computed tomography? J Nucl Cardiol 13: 635–41
Schölte AJ, Schuijf JD, Kharagjitsingh AV et al. (2008) Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart 94: 290–5
Kwong RY, Sattar H, Wu H, et al. (2008) Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 118: 1011–20
Agatston AS, Janowitz WR, Hildner FJ, et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15: 827–32
Raggi P, Shaw LJ, Berman DS, Callister TQ (2004) Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 43: 1663–9
Becker A, Leber A, Becker C, et al. (2008) Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years. BMC Cardiovascular Disorders 8: 27–35
Elkeles R, Godsland I, Feher M, et al. (2008) Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 29: 2244–51
Silverman M, Blaha M, Budoff M, et al. (2012) Potential implications of coronary artery calcium testing for guiding aspirin use among asymptomatic individuals with diabetes. Diabetes Care 35: 624–6
Handelsman Y, Mechanick J, Blonde L, et al. (2011) American association of clinical endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan. Endocrine Practice 17: 1–53
Wijns W, Kohl P, Danchin N, et al. (2010) Guidelines on myocardial revascularization. The Tak Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for cardio-thoracic Surgery (EACTS). Eur Heart J 31: 2501–55
Valensi P, Cosson E (2010) It’s not yet the time to stop screening diabetic patients for silent myocardial ischemia. Diabetes Metabolism 36: 91–6
Turrini F, Messora R, Giovanardi P, et al. (2009) Screening asymptomatic patients with diabetes for unknown coronary artery disease: Does it reduce risk? An open-label randomized trail comparing strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors. DADDY-D trial (Does coronary Atherosclerotic Deserve to be Diagnosed and treated early in Diabetics?) Trials 10: 119–26
Diamond GA, Kaul S, Shah PK (2007) Screen testing: cardiovascular prevention in asymptomatic diabetic patients. J Am Coll Cardiol 49: 1915–7
Anand DV, Lim ETS, Hopkins D, et al. (2006) Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J 27(6): 713–21
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Paris
About this paper
Cite this paper
Christiaens, L. (2013). Stratégie de dépistage de l’ischémie silencieuse chez le diabétique asymptomatique. In: Boyer, L., Guéret, P. (eds) Imagerie en coupes du cœur et des vaisseaux. Springer, Paris. https://doi.org/10.1007/978-2-8178-0435-4_5
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0435-4_5
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0434-7
Online ISBN: 978-2-8178-0435-4
eBook Packages: MedicineMedicine (R0)